Additional note to the end of the last thread. The stock at the Helix plant is going out of date, we offered to take it, but it is not a good look for the EU. HOWEVER, surely it will look even worse if these doses are left to go out of date.
The main issue, which I noted before, is that the EU have not changed their authorisation process, either for vaccine approval or manufacturing approval. They are still running sequential approvals, step by step, before moving to the next step. Very early on we moved to concurrent. It's just another illustration of how the EU has not been flexible enough to respond to emergency. They accuse us of moving too quickly, and endangering lives....... well, the opposite of that is of course, where they now find themselves, move slowly and inflexibly, and you too endanger lives.